NOVARTIS AG group: subsidiaries and structure
Aktiengesellschaft (AG) · Basel, Switzerland · LEI 5493007HIVTX6SY6XD66
16subsidiaries
6countries
11held directly
5lapsed LEIs
5links on accounts older than 24 months
27ISINs of subsidiaries
Summary
NOVARTIS AG is the ultimate parent of 16 subsidiaries with LEIs in 6 countries, as reported to GLEIF. 11 are held directly; the others sit below intermediate companies. The largest numbers are in Switzerland (5), in Austria (4) and in India (2). 5 of the subsidiaries have a lapsed LEI, and 5 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 10 ISINs for the parent and 27 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
5 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
NOVARTIS BIOVENTURES AG Switzerland
NOVARTIS HOLDING AG Switzerland
Novartis Kapital AG Switzerland
NOVARTIS FINANCE SA Luxembourg
Novartis Investments S.à r.l. Luxembourg
Novartis International AG Switzerland
NOVARTIS PHARMA AG Switzerland
NOVARTIS INDIA LIMITED India
NOVARTIS CAPITAL CORPORATION United States
NOVARTIS SERVICES, INC. United States
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| Alcon Ophthalmika GmbH | Austria | Wien | 5299004GW434UWQQ5843 | 2016 | lapsed > 24 months |
| EBEWE Pharma Ges.m.b.H. Nfg.KG | Austria | Unterach am Attersee | 52990041KEHDGNQJ6L80 | 2019 | lapsed > 24 months |
| Novartis Pharma GmbH | Austria | Wien | 529900OVNGQLN18QMN97 | 2019 | lapsed > 24 months |
| Sandoz GmbH | Austria | Kundl | 529900KYQPVVZTT2RC96 | 2019 | lapsed > 24 months |
| NOVARTIS INVESTMENT, LTD. | Bermuda | Hamilton | 549300S6XZACD3RT6T67 | 2020 | lapsed > 24 months |
| NOVARTIS BIOVENTURES AG | Switzerland | Basel | 549300G2OLUNX7CRZC04 | 2024 | |
| NOVARTIS HOLDING AG | Switzerland | Basel | 549300PEK0AU35HVR544 | 2024 | |
| Novartis International AG | Switzerland | Basel | 549300KOEGEOVTQF6R51 | 2024 | |
| Novartis Kapital AG | Switzerland | Basel | 213800IFUP4GS3MHMJ27 | 2025 | |
| NOVARTIS PHARMA AG | Switzerland | Basel | 5493003B21V1L9F31J13 | 2024 | |
| NOVARTIS HEALTHCARE PRIVATE LIMITED | India | MUMBAI | 3358009A3GQFRWVNFL21 | 2024 | |
| NOVARTIS INDIA LIMITED | India | MUMBAI | 335800MD8SVYXUDLTP28 | 2025 | |
| NOVARTIS FINANCE SA | Luxembourg | Luxembourg | 549300J537IQK62XT333 | 2024 | |
| Novartis Investments S.à r.l. | Luxembourg | Luxembourg | 549300F05GC5GGHTPC72 | 2024 | |
| NOVARTIS CAPITAL CORPORATION | United States | WILMINGTON | 5493002KF87V5RSRQS84 | 2024 | |
| NOVARTIS SERVICES, INC. | United States | WILMINGTON | 549300JNT70T24ZW4W77 | 2024 |